In a patient with polyarteritis nodosa and hand ischemia, should a contrast‑enhanced CT angiogram be ordered, and what contrast protocol is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CT Angiography for Polyarteritis Nodosa with Hand Ischemia

Order a contrast-enhanced CT angiography (CTA) with arterial phase imaging to evaluate hand ischemia in polyarteritis nodosa, though be aware that catheter-based conventional angiography remains the gold standard and may be necessary if CTA is negative despite high clinical suspicion.

Contrast Protocol

CTA requires intravenous contrast administration - CT without contrast is inadequate for vascular assessment 1. The optimal protocol is:

  • Biphasic acquisition: Noncontrast phase followed by arterial phase
  • Triphasic option: Add delayed/venous phase for comprehensive vessel lumen and wall assessment 1
  • For hand ischemia specifically, ensure coverage extends through the upper extremities to capture the entire arterial tree from proximal sources to distal hand vessels

Critical Diagnostic Considerations

Why CTA May Not Be Sufficient

Catheter-based angiography provides superior resolution and remains the diagnostic gold standard 2. Recent case reports emphasize this limitation - two patients initially diagnosed with cutaneous arteritis (limited disease) were only correctly diagnosed with systemic PAN after catheter angiography revealed abnormalities that were completely missed on contrast-enhanced CT and CTA 3. This is particularly relevant when systemic symptoms are limited but hand ischemia suggests medium-vessel involvement.

Expected Angiographic Findings

In PAN, you should look for:

  • Occlusive lesions (present in 98% of cases): luminal irregularity, stenosis, or complete occlusion 4
  • Aneurysms (present in 61% of cases): multiple small aneurysms or segments of ectasia 4
  • Skeletal muscle artery involvement occurs in approximately 32% of patients, including extremity vessels 4
  • Beaded appearance of arteries with multiple small aneurysms 5

When to Proceed Directly to Catheter Angiography

Consider bypassing CTA and proceeding directly to conventional catheter angiography when:

  • High clinical suspicion for PAN with hand ischemia (medium-vessel territory)
  • CTA is negative but clinical suspicion remains high 3
  • Treatment decisions depend on precise vascular mapping
  • Patient can tolerate the procedure (complication rate is very low at <1%) 2

Clinical Context for Imaging Decision

The 2021 ACR/Vasculitis Foundation guidelines indicate that vascular imaging helps validate diagnosis and determine disease severity, which influences treatment decisions 2. Hand ischemia represents medium-vessel involvement and warrants imaging regardless of other systemic symptoms.

Alternative Imaging Modalities

  • MR angiography: Noninvasive alternative to CTA with similar diagnostic utility 2
  • FDG-PET/CT: Can detect vessel wall inflammation; optimal timing is 2.5 hours post-injection with target glucose <126 mg/dL 1, 6
  • Doppler ultrasound: Initial screening tool but insufficient for definitive diagnosis in PAN 7

Common Pitfall

Do not assume CTA will definitively rule out PAN - the literature demonstrates cases where only catheter angiography revealed diagnostic findings 3. If your clinical suspicion is high based on hand ischemia, mononeuropathy multiplex, or other systemic features, maintain a low threshold for proceeding to conventional angiography even after negative or equivocal CTA results.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.